# Alveus Therapeutics funding rounds and investors

As of 14 Oct 2026, Alveus Therapeutics has raised $160M across 1 verified round on record; latest: $160 million Series A led by Andera Partners, New Rhein Healthcare Investors and 1 other, announced 8 Jan 2026.

Alveustx specializes in developing next-generation treatments for obesity and metabolic diseases.

Website: https://alveustx.com  
Page: https://fireround.dev/companies/alveustx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-01-08 | Series A | $160 million | Andera Partners, New Rhein Healthcare Investors, Omega Funds | Avego BioScience Capital, Kurma Partners, Sanofi Ventures | [biopharmadive.com](https://www.biopharmadive.com/news/alveus-obesity-biotech-startup-glp-gipr-amylin-financing/809148) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.